CA2298762C - Compositions therapeutiques consistant en du silicate de sodium soluble multi-filtre clarifie sous forme liquide capables de modifier les cellules suppresseurs et de stimuler le systeme immunitaire humain afin de prevenir la recurrence des infections a herpes - Google Patents

Compositions therapeutiques consistant en du silicate de sodium soluble multi-filtre clarifie sous forme liquide capables de modifier les cellules suppresseurs et de stimuler le systeme immunitaire humain afin de prevenir la recurrence des infections a herpes Download PDF

Info

Publication number
CA2298762C
CA2298762C CA002298762A CA2298762A CA2298762C CA 2298762 C CA2298762 C CA 2298762C CA 002298762 A CA002298762 A CA 002298762A CA 2298762 A CA2298762 A CA 2298762A CA 2298762 C CA2298762 C CA 2298762C
Authority
CA
Canada
Prior art keywords
sodium silicate
recurrence
herpes
immune system
clarified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002298762A
Other languages
English (en)
Other versions
CA2298762A1 (fr
Inventor
Paul M. Pidcock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002298762A priority Critical patent/CA2298762C/fr
Publication of CA2298762A1 publication Critical patent/CA2298762A1/fr
Application granted granted Critical
Publication of CA2298762C publication Critical patent/CA2298762C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CA002298762A 2000-02-11 2000-02-11 Compositions therapeutiques consistant en du silicate de sodium soluble multi-filtre clarifie sous forme liquide capables de modifier les cellules suppresseurs et de stimuler le systeme immunitaire humain afin de prevenir la recurrence des infections a herpes Expired - Fee Related CA2298762C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002298762A CA2298762C (fr) 2000-02-11 2000-02-11 Compositions therapeutiques consistant en du silicate de sodium soluble multi-filtre clarifie sous forme liquide capables de modifier les cellules suppresseurs et de stimuler le systeme immunitaire humain afin de prevenir la recurrence des infections a herpes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002298762A CA2298762C (fr) 2000-02-11 2000-02-11 Compositions therapeutiques consistant en du silicate de sodium soluble multi-filtre clarifie sous forme liquide capables de modifier les cellules suppresseurs et de stimuler le systeme immunitaire humain afin de prevenir la recurrence des infections a herpes

Publications (2)

Publication Number Publication Date
CA2298762A1 CA2298762A1 (fr) 2000-12-02
CA2298762C true CA2298762C (fr) 2001-06-12

Family

ID=4165332

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002298762A Expired - Fee Related CA2298762C (fr) 2000-02-11 2000-02-11 Compositions therapeutiques consistant en du silicate de sodium soluble multi-filtre clarifie sous forme liquide capables de modifier les cellules suppresseurs et de stimuler le systeme immunitaire humain afin de prevenir la recurrence des infections a herpes

Country Status (1)

Country Link
CA (1) CA2298762C (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2411833A (en) * 2004-03-08 2005-09-14 Skin Salveation Ltd Composition for use in the treatment of dry skin conditions
WO2009052090A2 (fr) * 2007-10-15 2009-04-23 7 Oaks Pharmaceutical Corporation Compositions à base de silicate et procédé de traitement
GB201402672D0 (en) 2014-02-14 2014-04-02 Medical Res Council Materials and methods relating to stabilised polymeric silicate compositions
WO2021245095A1 (fr) * 2020-06-02 2021-12-09 INSERM (Institut National de la Santé et de la Recherche Médicale) Procédé d'amélioration des immunothérapies

Also Published As

Publication number Publication date
CA2298762A1 (fr) 2000-12-02

Similar Documents

Publication Publication Date Title
KR100347651B1 (ko) 단순포진바이러스및다른감염성질병의치료를위한항균성조성물
AU746756B2 (en) A method of inhibiting formation of infectious herpes virus particles
US4585656A (en) Treatment of herpes
JPH08502074A (ja) 組織の保護及び再生組成物
JP4105535B2 (ja) 抗ウイルス性物質
EP1643846A1 (fr) Methode de traitement de plaies et de lesions de la peau
CA2298762C (fr) Compositions therapeutiques consistant en du silicate de sodium soluble multi-filtre clarifie sous forme liquide capables de modifier les cellules suppresseurs et de stimuler le systeme immunitaire humain afin de prevenir la recurrence des infections a herpes
JPH06506212A (ja) Ｈｉｖウイルス系疾病、ヘルペス、色素性網膜炎およびマラリアの治療向けリボフラビンの利用
CN113855654A (zh) 一种预防和治疗冠状病毒感染的组合物
WO1986000811A1 (fr) Preparations therapeutiques pour le traitement de certaines maladies d'origine virale ou autre et leur production
Olsen et al. Effect of treatment with exogenous interferon, polyriboinosinic-polyribocytidylic acid, or polyriboinosinic-polyribocytidylic acid-poly-L-lysine complex on Herpesvirus hominis infections in mice
US4162308A (en) Water soluble extracts of certain marine red algae and processes for use thereof
AU2018324427B2 (en) Methods and compositions for the antiviral use of synthetic lysine analogs and mimetics
CN103153312B (zh) 用于预防性治疗和治疗性治疗疱疹感染的吡罗昔康
Konigheim et al. Cytotoxicity and antiviral activity of a lignan extracted from Larrea divaricata
EP3295934B1 (fr) Composition pharmaceutique antivirale à usage topique
JPS5970615A (ja) 口唇疱疹治療へのウンデシレン酸の使用
JPH03500656A (ja) ウイルス感染の治療および予防薬剤アシル・カルニチン
JPS63501422A (ja) 生殖器及び口腔ヘルペスの治療方法
US3859433A (en) Antiviral treatment
US3148113A (en) Concurrent oral administration of glucosamine with a tetracycline antibiotic for enhanced antibiotic blood levels
US20040235931A1 (en) Inhibition of herpes virus replication
GB2355192A (en) Anti-viral treatment
CA1197464A (fr) Traitement de l'herpes
Siwicki et al. Anti-Birnavirus Activity of Methisoprinol–in vitro Study with Infectious Pancreatic Necrosis Virus (IPNV)

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130211